Featured
Last news
Tenon Medical Reports First Quarter 2025 Financial Results
~ FDA Clearance of Catamaran® SI Joint Fusion System for New Indication to Augment Spinal Fusion ~~ Catamaran® SI Joint Fusion Technology Protected with Robust Patent Portfolio of Twelve U.S. and International Patents ~~ Received Gross Proceeds of ~$7.0 Million from Equity Financing Transactions ~~ National Commercial Launch of Catamaran SE in Mid-2025 ~
Dolphin Reports Q1 2025 Results; Core Entertainment Publicity and Marketing Segment (EPM) Revenue Up 2% YoY to $12.1 Million, Strategic Investments and New Division Launch to Drive Long-Term Growth
Highlights Talent Expansion, Women's Sports Investment, Affiliate Marketing Launches, and Continued Industry RecognitionNamed 2025 Agency of the Year by Observer's PR Power List
Theranexus and Beyond Batten Disease Foundation Announce Strong Positive Real-World Data Supporting Batten-1 Efficacy for the Treatment of Batten Disease
LYON, FRANCE and AUSTIN, TX / ACCESS Newswire / May 13, 2025 / Theranexus, a biopharmaceutical company developing drug candidates for rare neurological diseases, and the Beyond Batten Disease Foundation (BBDF) today announced new real-world data strongly supporting the efficacy of Batten-1 (miglustat) as a treatment for CLN3 disease, also known as juvenile Batten disease.
CERTIFY Health Secures Growth Equity Investment from ABS Capital Partners to Accelerate Patient Engagement Innovation
New Investment Accelerates CERTIFY Health's Mission to Revolutionize Patient Engagement and Streamline Healthcare Operations
CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
HOUSTON, TX / ACCESS Newswire / May 13, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced the pricing of its "reasonable best efforts" public offering with a single healthcare focused institutional investor for the purchase and sale of 3,952,570 shares of common stock of the Company (the "Common Stock) (or common stock equivalents in lieu thereof), at a purchase price of $1.265 per share of Common Stock. The Company further agreed to issue to the investors Series F Common Stock purchase warrants to purchase up to 3,952,570 shares of Common Stock (the "Series F Warrants"). The Series F Warrants will have an exercise price of $1.14 per share, will be exercisable immediately following the date of their issuance and will expire in five years.
Hypha Labs Files Multiple Additional Patents for its Ground Breaking Mushroom Accelerator
LAS VEGAS, NV / ACCESS Newswire / May 13, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the filing of additional patents with the United States Patent and Trade Office (USPTO) which it believes further protects the Company's innovations in the commercialization of a broad array of functional mushroom ingredients for the rapidly growing consumer and enterprise markets.
Dolphin Subsidiary The Digital Dept. Sees Surge In Affiliate Marketing Division, Driving Over $6.6 Million In Gross Retail Sales In First Quarter
LOS ANGELES, CA / ACCESS Newswire / May 13, 2025 / The Digital Dept., a leading influencer marketing agency and a subsidiary of Dolphin (NASDAQ:DLPN), is celebrating rapid early success from its recently launched Affiliate Marketing and Content Creator Services division. Since its debut in January, the division has already driven more than $6.6 million in affiliate-attributed sales in the first quarter, signaling strong demand for strategic affiliate support in today's creator economy.
REMSleep Enters Formal Agreement with Major Distributor
CLEARWATER, FL / ACCESS Newswire / May 13, 2025 / REMSleep Holdings, Inc. (OTC PINK:RMSL) Enters into Formal Agreement with www.1800CPAP.com , a major DME distributor. The DeltaWave is now available nationwide.
Xebra Brands Advances Commercialization Efforts with NF Skin
Summer 2025 Launch of ELEMENTS™ CBD Product Line in United States
CNS Pharmaceuticals Acquires Orphan Drug Designation for Novel, Late Stage Abeotaxane, TPI 287
Company advancing plans to develop TPI 287, a novel, late stage abeotaxane that appears to cross the blood-brain barrier and has published clinical efficacy data in glioblastoma multiforme (GBM)Management releases "What This Means" segment discussing the receipt of Orphan Drug Designations for TPI 287; Access here
Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy
Innovative Registry Harnesses Shock Wave Therapy to Advance Non-Drug Equine Asthma Treatment and Drive Evidence-Based Veterinary Care
BioNxt Reports Expanded Research, Development and Commercialization Capability with Centralized Munich Laboratory
VANCOUVER, BC / ACCESS Newswire / May 13, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, is pleased to announce the integration of its research, development and commercialization activities to the Gen-Plus GmbH & Co. KG (Gen-Plus) Contract Research and Development Organization (CRDO) in Munich, Germany. The move provides BioNxt with enhanced R&D capabilities, collaboration opportunities, and accelerated innovation potential within a major European biotech hub.
Nazi files found in champagne crates in Argentine court basement
A hoard of World War II-era Nazi propaganda and membership documents has been unearthed in the basement of Argentina's Supreme Court, where it has lain, stashed in champagne crates, since 1941.
Israel urges ICC to drop arrest warrants against PM
Israel has asked the International Criminal Court to dismiss its arrest warrants against Prime Minister Benjamin Netanyahu and former defence minister Yoav Gallant while ICC judges reconsider complex jurisdictional questions.
Poland to close Russian consulate in Krakow over 'sabotage'
Poland's top diplomat said on Monday he ordered the closure of a Russian consulate over "sabotage", after authorities accused Russia of orchestrating a fire that destroyed a Warsaw shopping centre last year.
Kim Kardashian testifies in Paris multi-million-dollar robbery trial
A-list celebrity Kim Kardashian is to testify in a Paris court on Tuesday, an eagerly awaited appearance nearly a decade after being robbed of millions of dollars of jewellery during the French capital's fashion week.
Film legend Bardot backs Depardieu ahead of sexual assault verdict
Brigitte Bardot has defended two French actors accused of sexual assault including fellow screen legend Gerard Depardieu, saying they should be allowed to "get on with their lives" in an interview with French channel BFM broadcast Monday.
Peru hopes local miracle gets recognition under new pope
In the small Peruvian town of Eten, the faithful flock every year to celebrate an apparent 17th century miracle featuring images of the child Jesus, a sacred phenomenon not yet recognized by the Vatican.
New to The Street Spotlights Innovation and Excellence Tonight on Fox Business Network at 10:30 PM PST, Featuring KITON, Synergy CHC, Health In Tech, Skip Barber Racing School, and LightPath Technologies
Presented as sponsored programming by The Sustainable Green Team's WaterLess Garden™ and PetVivo Holdings' SPRYNG™, the episode highlights global leaders across fashion, wellness, health tech, motorsports, and photonics.
Michael DeMayo Charlotte Attorney Named Leader in Law
As founder and managing attorney of DeMayo Law Offices, Michael A. DeMayo was named a 2023 Leader in Law by North Carolina Lawyers Weekly, spotlighting his decades-long dedication to justice and community impact.
The Inheritance Nobody Wants: How Alzheimer's Steals Futures Before It Claims Memories
AFOF Sets $2 Million Fundraising Goal to Expand Caregiver Support in 2025
Wrapped In Her Love by Ruki Renov Celebrates the Legacy of Rozi Davis Davidowitz — A Timeless Icon of Compassion and Community Leadership
NAPERVILLE, IL / ACCESS Newswire / May 12, 2025 / In the deeply moving new release Wrapped In Her Love, author Ruki Renov honors the extraordinary life of her mother, Rozi Davis Davidowitz, affectionately known as Ema. This heartfelt biography, now available on Amazon Kindle, offers an inspiring portrait of a woman whose love, wisdom, and leadership shaped countless lives across generations and cultures.
The International Powder and Bulk Solids Show Focuses on Processing Progress in Sustainability, Ethics and Safety
ROSEMONT, IL / ACCESS Newswire / May 12, 2025 / The International Powder and Bulk Solids Conference and Exhibition (iPBS), North America's largest biennial event for the processing and bulk solids handling industry, welcomed over 5,000 professionals, uniting top industry minds in materials processing and innovation under one roof. From automation to sustainability, iPBS serves as the critical forum for knowledge sharing, hands-on demonstrations from brands including Rembe providing new technologies for dust combustion safety, discussions providing pathways for younger generations to enter the sector and meaningful community building through on-floor activations.
What are Dental Implant Crowns? What to Know
NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / When it comes to dental implants vs crowns, which element is the most important? Titanium implants give your dental implant reconstruction strength and stability, but dental crowns complete your smile and let you eat your favorite meals. A dental crown is an artificial tooth that's placed atop your dental implant. Usually crafted from tooth-like materials such as zirconia or porcelain, crowns are custom-created to match your natural teeth for a seamless smile. Let's learn more about dental crowns and how they work.
Longevity-Focused Wellness Expo to Debut in West Palm Beach
Tickets are on sale to attend The Longevity Expo from May 31 to June 1, hosted by The New York Times bestselling author, Sara Szal Gottfried, M.D.
New Awards Program Launches to Celebrate Excellence in Architectural Design
Architectural Record Introduces a Multi-Category Competition Honoring Outstanding Projects and Individual Achievement in Architecture
Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company
KELOWNA, BC / ACCESS Newswire / May 12, 2025 / Lexaria Bioscience Corp. (Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides this update on corporate developments.
Secarna Pharmaceuticals and Curie.Bio Portfolio Company Enter into Research and Option Agreement
MUNICH, DE / ACCESS Newswire / May 12, 2025 / Secarna Pharmaceuticals GmbH & Co. KG, a company redefining the discovery and development of best-in-class oligonucleotide therapeutics, today announced the signing of a research and option agreement for a scientific and strategic collaboration with one of Curie.Bio's portfolio companies.
Ensysce Biosciences Bolsters Management Team with Regulatory Expert
~ Advanced Preparation for New Drug Application ~
Ainos Reports First Quarter 2025 Financial Results
Q1 revenues increased 412% year over year, driven by AI Nose productsDelivers strong turnaround from gross loss to gross profit in Q1AI Nose gains traction beyond healthcare with strategic partnerships in robotics and semiconductor sectorsVELDONA® program advances with TFDA and IRB Approvals for two clinical trials in Taiwan
CASI Pharmaceuticals Enters Into Definitive Agreement for the Divestiture of Assets in China
BEIJING, CHINA / ACCESS Newswire / May 12, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that it has entered into a definitive Equity and Assets Transfer Agreement (the "Equity and Assets Transfer Agreement") with Kaixin Pharmaceuticals Inc. ("Kaixin Pharmaceuticals"), a Cayman Islands incorporated entity wholly-owned by Dr. Wei-Wu He, Chairman of the board of directors and CEO of the Company and two direct wholly-owned subsidiaries of the Company in China (the "Target Companies"), pursuant to which the Company shall sell and transfer, and Kaixin Pharmaceuticals shall purchase and acquire, 100% equity interests in both Target Companies (the "Target Equity Interests"), and all licensing rights, distribution rights, supply arrangements and related rights related to BI-1206 (in China), CID-103(in Asia excluding Japan) and Thiotepa (in China excluding Hong Kong, Macau and Taiwan) (the "Target Pipeline Products") for an aggregate purchase price of $20.0 million, which shall include assumption of up to $20.0 million of indebtedness of the Company (the "Transaction").
Brenmiller Energy and New York Power Authority Showcase Thermal Energy Storage Success at SUNY Purchase College
Innovative pilot project highlights the role of thermal energy storage in decarbonizing public institutionsPilot installations offer replicable frameworks for wider adoptionBrenmiller's bGen™ intended to reduce 550 metric tons of CO2 emissions annuallyThe project and its key findings will be presented in a webinar on May 19, 2025 hosted by the Renewable Thermal Collaborative